Drug intelligence / Profile preview

siBAHD1

Development stage
Preclinical
Lead developer
National Cancer Centre Singapore
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

siBAHD1 is a small interfering RNA (siRNA) designed to silence the expression of the Bromo Adjacent Homology Domain Containing 1 (BAHD1) protein. BAHD1 is a chromatin-associated factor that plays a critical role in the formation of heterochromatin and the silencing of genes, specifically through the recruitment of histone methyltransferases that catalyze H3K9me3 and H3K27me3 modifications. Research presented at the AACR 2025 Annual Meeting identified BAHD1-dependent heterochromatin formation as a key mechanism underlying acquired radioresistance in prostate and head and neck cancers. By knocking down BAHD1, siBAHD1 reduces the expression of repressive heterochromatin markers and restores sensitivity to radiation in previously resistant cancer cell models. This suggests that targeting the BAHD1-heterochromatin axis may provide a novel therapeutic approach to overcome radioresistance in clinical oncology.

Other names
BAHD1 siRNABAHD-1 siRNABAHD 1 siRNAsiRNA targeting BAHD1
02

Targets

BAHD1 (Bromo adjacent homology domain-containing protein 1)

Beyond the preview

Go deeper on siBAHD1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siBAHD1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call